Addus HomeCare Announces Second Quarter 2022 Financial Results
Second Quarter 2022 Highlights:
-
Revenues Grow 8.7% to
$236.9 Million -
Net Income of
$11.3 Million , or$0.70 per Diluted Share -
Adjusted Earnings per Diluted Share Increases to
$0.91 -
Adjusted EBITDA Increases 3.1% to
$25.1 Million -
Cash flow from operations of
$56.5 Million
Overview
Net service revenues were
For the first six months of 2022, net service revenues increased 9.5% to
Commenting on the results,
“Our results for the second quarter reflect positive trends in each of our operating segments. Personal care revenues, which accounted for 73.6% of overall revenue, were up 2.5% on a same-store basis. The 24.6% growth in home health reflects strong admissions and the addition of the operations of
Cash and Liquidity
The Company has focused on maintaining a strong financial position in 2022. During the second quarter, Addus paid down approximately
Looking Ahead
Allison added, “We continue to see opportunities for growth both organically and through acquisitions. Our strategic focus is to target expansion opportunities in states where we have a strong existing presence. Acquisitions remain an integral part of our growth strategy, and we continue to have a robust pipeline of acquisition opportunities. We remain well-capitalized and have the flexibility to pursue acquisitions that meet our criteria in all our service lines.
“The COVID-19 pandemic and reduced availability of hospital beds over the past two years pushed more care delivery to the home setting, with favorable patient outcomes and satisfaction driving higher demand. Addus has been a leader in providing quality home-based patient care with a proven operating model across the care continuum, and we are well positioned for continued growth in the home care sector. We have continued to make investments in data analytic capabilities and technologies to drive efficiencies and enhance caregivers’ abilities to coordinate effective care in the home and we believe we’re currently managing labor and other industry challenges effectively. As always, our primary objective is to provide outstanding care to our patients and their families, and we look forward to the opportunities ahead,” said Allison.
Non-GAAP Financial Measures
The information provided in this release includes adjusted net income, adjusted EBITDA and adjusted net income per diluted share, which are non-GAAP financial measures. The Company defines adjusted net income as net income before acquisition and de novo expenses, stock-based compensation expense, restructure expenses and other costs, gain or loss on the sale of assets, and retroactive rate increases from
Conference Call
Addus will host a conference call on
A live broadcast of Addus HomeCare’s conference call will be available under the Investor Relations section of the Company’s website: www.addus.com. An online replay will also be available on the Company’s website for one month, beginning approximately two hours following the conclusion of the live broadcast.
Forward-Looking Statements
Certain matters discussed in this press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may be identified by words such as “preliminary,” “continue,” “expect,” and similar expressions. These forward-looking statements are based on our current expectations and beliefs concerning future developments and their potential effect on us. Forward-looking statements involve a number of risks and uncertainties that may cause actual results to differ materially from those expressed or implied by such forward-looking statements, including discretionary determinations by government officials, the consummation and integration of acquisitions, anticipated transition to managed care providers, our ability to successfully execute our growth strategy, unexpected increases in SG&A and other expenses, expected benefits and unexpected costs of acquisitions and dispositions, management plans related to dispositions, the possibility that expected benefits may not materialize as expected, the failure of the business to perform as expected, changes in reimbursement, changes in government regulations, changes in Addus HomeCare’s relationships with referral sources, increased competition for Addus HomeCare’s services, changes in the interpretation of government regulations, the uncertainty regarding the outcome of discussions with managed care organizations, changes in tax rates, the impact of adverse weather, higher than anticipated costs, lower than anticipated cost savings, estimation inaccuracies in future revenues, margins, earnings and growth, whether any anticipated receipt of payments will materialize, any future impact to our business operations, reimbursements and patient population due to the recent COVID-19 global pandemic, and other risks set forth in the Risk Factors section in Addus HomeCare’s Annual Report on Form 10-K filed with the
About
ADDUS HOMECARE CORPORATION AND SUBSIDIARIES | |||||||||||||||
Condensed Consolidated Statements of Income | |||||||||||||||
(amounts and shares in thousands, except per share data) | |||||||||||||||
(Unaudited) | |||||||||||||||
Income Statement Information: |
For the Three Months
Ended |
For the Six Months
Ended |
|||||||||||||
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
||||
Net service revenues |
$ |
236,940 |
|
$ |
217,893 |
|
$ |
463,574 |
|
$ |
423,195 |
|
|||
Cost of service revenues |
|
161,342 |
|
|
149,083 |
|
|
317,790 |
|
|
293,188 |
|
|||
Gross profit |
|
75,598 |
|
|
68,810 |
|
|
145,784 |
|
|
130,007 |
|
|||
|
31.9 |
% |
|
31.6 |
% |
|
31.4 |
% |
|
30.7 |
% |
||||
General and administrative expenses |
|
55,095 |
|
|
48,175 |
|
|
108,247 |
|
|
93,601 |
|
|||
Depreciation and amortization |
|
3,609 |
|
|
3,587 |
|
|
7,130 |
|
|
7,188 |
|
|||
Total operating expenses |
|
58,704 |
|
|
51,762 |
|
|
115,377 |
|
|
100,789 |
|
|||
Operating income |
|
16,894 |
|
|
17,048 |
|
|
30,407 |
|
|
29,218 |
|
|||
Total interest expense, net |
|
1,878 |
|
|
1,231 |
|
|
3,640 |
|
|
2,425 |
|
|||
Income before income taxes |
|
15,016 |
|
|
15,817 |
|
|
26,767 |
|
|
26,793 |
|
|||
Income tax expense |
|
3,766 |
|
|
4,220 |
|
|
7,047 |
|
|
6,302 |
|
|||
Net income |
$ |
11,250 |
|
$ |
11,597 |
|
$ |
19,720 |
|
$ |
20,491 |
|
|||
Net income per diluted share: |
$ |
0.70 |
|
$ |
0.72 |
|
$ |
1.22 |
|
$ |
1.28 |
|
|||
Weighted average number of common shares outstanding: | |||||||||||||||
Diluted |
|
16,131 |
|
|
16,043 |
|
|
16,113 |
|
|
16,063 |
|
|||
Cash Flow Information: | For the Three Months Ended |
For the Six Months Ended |
|||||||||||||
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
||||
Net cash provided by (used in) operating activities |
$ |
56,519 |
|
$ |
15,045 |
|
$ |
62,502 |
|
$ |
(3,321 |
) |
|||
Net cash (used in) investing activities |
|
(434 |
) |
|
(907 |
) |
|
(86,028 |
) |
|
(1,928 |
) |
|||
Net cash (used in) financing activities |
|
(59,931 |
) |
|
(285 |
) |
|
(24,452 |
) |
|
(429 |
) |
|||
Net change in cash |
|
(3,846 |
) |
|
13,853 |
|
|
(47,978 |
) |
|
(5,678 |
) |
|||
Cash at the beginning of the period |
|
124,763 |
|
|
125,547 |
|
|
168,895 |
|
|
145,078 |
|
|||
Cash at the end of the period |
$ |
120,917 |
|
$ |
139,400 |
|
$ |
120,917 |
|
$ |
139,400 |
|
|||
ADDUS HOMECARE CORPORATION AND SUBSIDIARIES | |||||||
Condensed Consolidated Balance Sheets | |||||||
(Amounts in thousands) | |||||||
(Unaudited) | |||||||
|
2022 |
|
2021 |
||||
Assets | |||||||
Current assets | |||||||
Cash |
$ |
120,917 |
$ |
139,400 |
|||
Accounts receivable, net |
|
124,554 |
|
138,270 |
|||
Prepaid expenses and other current assets |
|
10,901 |
|
12,740 |
|||
Total current assets |
|
256,372 |
|
290,410 |
|||
Property and equipment, net |
|
17,733 |
|
18,708 |
|||
Other assets | |||||||
|
574,752 |
|
469,476 |
||||
Intangible assets, net |
|
74,464 |
|
67,247 |
|||
Deferred tax assets, net |
|
- |
|
6,128 |
|||
Operating lease assets |
|
41,207 |
|
37,191 |
|||
Total other assets |
|
690,423 |
|
580,042 |
|||
Total assets |
$ |
964,528 |
$ |
889,160 |
|||
Liabilities and stockholders' equity | |||||||
Current liabilities | |||||||
Accounts payable |
$ |
21,346 |
$ |
23,942 |
|||
Accrued payroll |
|
39,432 |
|
33,836 |
|||
Accrued expenses |
|
38,054 |
|
35,717 |
|||
Government stimulus advance |
|
16,735 |
|
8,094 |
|||
Accrued workers compensation |
|
12,437 |
|
14,382 |
|||
Current portion of long-term debt, net of debt issuance costs |
|
- |
|
973 |
|||
Total current liabilities |
|
128,004 |
|
116,944 |
|||
Long-term debt, less current portion, net of debt issuance costs |
|
196,342 |
|
193,714 |
|||
Long-term lease liability, less current portion |
|
38,343 |
|
34,339 |
|||
Other long-term liabilities |
|
2,062 |
|
108 |
|||
Total long-term liabilities |
|
236,747 |
|
228,161 |
|||
Total liabilities |
|
364,751 |
|
345,105 |
|||
Total stockholders' equity |
|
599,777 |
|
544,055 |
|||
Total liabilities and stockholders' equity |
$ |
964,528 |
$ |
889,160 |
|||
ADDUS HOMECARE CORPORATION AND SUBSIDIARIES | ||||||||||||||||||
Net Service Revenue by Segment | ||||||||||||||||||
(Amounts in thousands) | ||||||||||||||||||
(Unaudited) | ||||||||||||||||||
For the Three Months
|
For the Six Months
|
|||||||||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
|||||||||||
Net Service Revenues by Segment | ||||||||||||||||||
Personal Care |
$ |
174,330 |
$ |
176,267 |
$ |
343,962 |
$ |
341,135 |
||||||||||
Hospice |
|
52,074 |
|
36,909 |
|
99,801 |
|
73,003 |
||||||||||
|
10,536 |
|
4,717 |
|
19,811 |
|
9,057 |
|||||||||||
Total Revenue |
$ |
236,940 |
$ |
217,893 |
$ |
463,574 |
$ |
423,195 |
||||||||||
ADDUS HOMECARE CORPORATION AND SUBSIDIARIES |
||||||||||||||||
Key Statistical and Financial Data (Unaudited) |
||||||||||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
|
For the Three Months
|
|
For the Six Months
|
||||||||||||
|
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||||||
Personal Care | ||||||||||||||||
States served at period end |
|
- |
|
|
- |
|
|
21 |
|
|
22 |
|
||||
Locations at period end |
|
- |
|
|
- |
|
|
161 |
|
|
164 |
|
||||
Average billable census total |
|
37,501 |
|
|
38,493 |
|
|
37,041 |
|
|
38,410 |
|
||||
Billable hours (in thousands) |
|
7,373 |
|
|
7,650 |
|
|
14,474 |
|
|
15,187 |
|
||||
Average billable hours per census per month |
|
65.2 |
|
|
65.9 |
|
|
64.8 |
|
|
65.6 |
|
||||
Billable hours per business day |
|
113,426 |
|
|
117,688 |
|
|
112,198 |
|
|
117,729 |
|
||||
Revenues per billable hour |
$ |
23.58 |
|
$ |
22.60 |
|
$ |
23.61 |
|
$ |
22.42 |
|
||||
Organic growth | ||||||||||||||||
- Revenue |
|
2.5 |
% |
|
7.4 |
% |
|
1.7 |
% |
|
5.9 |
% |
||||
Hospice | ||||||||||||||||
Locations served at period end |
|
- |
|
|
- |
|
|
33 |
|
|
33 |
|
||||
Admissions |
|
3,281 |
|
|
2,252 |
|
|
6,596 |
|
|
4,646 |
|
||||
Average daily census |
|
3,333 |
|
|
2,460 |
|
|
3,323 |
|
|
2,430 |
|
||||
Average discharge length of stay |
|
83.8 |
|
|
89.3 |
|
|
84.0 |
|
|
95.6 |
|
||||
Patient days |
|
303,289 |
|
|
223,901 |
|
|
578,777 |
|
|
439,908 |
|
||||
Revenue per patient day |
$ |
171.70 |
|
$ |
164.85 |
|
$ |
172.43 |
|
$ |
165.95 |
|
||||
Organic growth | ||||||||||||||||
- Revenue |
|
2.5 |
% |
|
(8.4 |
)% |
|
3.4 |
% |
|
(8.4 |
)% |
||||
- Average daily census |
|
6.1 |
% |
|
(14.3 |
)% |
|
6.6 |
% |
|
(27.2 |
)% |
||||
Locations served at period end |
|
- |
|
|
- |
|
|
12 |
|
|
10 |
|
||||
New Admissions |
|
3,351 |
|
|
1,186 |
|
|
6,687 |
|
|
2,354 |
|
||||
Recertifications |
|
1,409 |
|
|
738 |
|
|
2,725 |
|
|
1,395 |
|
||||
Total Volume |
|
4,760 |
|
|
1,924 |
|
|
9,412 |
|
|
3,749 |
|
||||
Visits |
|
68,452 |
|
|
31,582 |
|
|
133,665 |
|
|
59,247 |
|
||||
Organic growth | ||||||||||||||||
- Revenue |
|
24.6 |
% |
|
24.7 |
% |
|
12.6 |
% |
|
11.5 |
% |
||||
- New admissions |
|
25.2 |
% |
|
29.5 |
% |
|
13.9 |
% |
|
21.5 |
% |
||||
- Volume |
|
20.6 |
% |
|
19.9 |
% |
|
16.5 |
% |
|
12.3 |
% |
||||
Percentage of Revenues by Payor: | ||||||||||||||||
Personal Care | ||||||||||||||||
State, local and other governmental programs |
|
49.0 |
% |
|
50.2 |
% |
|
49.2 |
% |
|
49.6 |
% |
||||
Managed care organizations |
|
46.2 |
|
|
44.7 |
|
|
45.9 |
|
|
45.2 |
|
||||
Private duty |
|
2.7 |
|
|
2.9 |
|
|
2.7 |
|
|
2.9 |
|
||||
Commercial |
|
1.2 |
|
|
1.5 |
|
|
1.2 |
|
|
1.5 |
|
||||
Other |
|
0.9 |
% |
|
0.7 |
% |
|
1.0 |
% |
|
0.8 |
% |
||||
Hospice | ||||||||||||||||
Medicare |
|
90.5 |
% |
|
93.3 |
% |
|
90.8 |
% |
|
93.8 |
% |
||||
Commercial |
|
5.2 |
|
|
2.6 |
|
|
5.0 |
|
|
2.0 |
|
||||
Managed care organizations |
|
3.8 |
|
|
3.8 |
|
|
3.7 |
|
|
3.9 |
|
||||
Other |
|
0.5 |
% |
|
0.3 |
% |
|
0.5 |
% |
|
0.3 |
% |
||||
Medicare |
|
72.1 |
% |
|
81.1 |
% |
|
72.7 |
% |
|
80.9 |
% |
||||
Managed care organizations |
|
21.5 |
|
|
17.4 |
|
|
21.0 |
|
|
17.9 |
|
||||
Commercial |
|
6.2 |
|
|
1.5 |
|
|
6.1 |
|
|
1.2 |
|
||||
Other |
|
0.2 |
% |
|
0.0 |
% |
|
0.2 |
% |
|
0.0 |
% |
ADDUS HOMECARE CORPORATION AND SUBSIDIARIES |
||||||||||||||||
Reconciliation of Non-GAAP Financial Measures |
||||||||||||||||
(amounts in thousands, except per share data) |
||||||||||||||||
(Unaudited) (1) |
||||||||||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
|
For the Three Months
|
|
For the Six Months
|
||||||||||||
|
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||||||
Reconciliation of Adjusted EBITDA to Net Income: (2) | ||||||||||||||||
Net income |
$ |
11,250 |
|
$ |
11,597 |
|
$ |
19,720 |
|
$ |
20,491 |
|
||||
Interest expense, net |
|
1,878 |
|
|
1,231 |
|
|
3,640 |
|
|
2,425 |
|
||||
(Gain) Loss on sale of assets |
|
(2 |
) |
|
16 |
|
|
(2 |
) |
|
16 |
|
||||
Income tax expense |
|
3,766 |
|
|
4,220 |
|
|
7,047 |
|
|
6,302 |
|
||||
Depreciation and amortization |
|
3,609 |
|
|
3,587 |
|
|
7,130 |
|
|
7,188 |
|
||||
Impact of retroactive |
|
- |
|
|
(1,438 |
) |
|
- |
|
|
- |
|
||||
COVID-19 expense, net |
|
- |
|
|
- |
|
|
- |
|
|
(591 |
) |
||||
Acquisition and de novo expenses |
|
1,831 |
|
|
2,245 |
|
|
4,624 |
|
|
3,720 |
|
||||
Stock-based compensation expense |
|
2,680 |
|
|
2,525 |
|
|
5,165 |
|
|
4,764 |
|
||||
Restructure and other non-recurring costs |
|
89 |
|
|
352 |
|
|
186 |
|
|
754 |
|
||||
Adjusted EBITDA |
$ |
25,101 |
|
$ |
24,335 |
|
$ |
47,510 |
|
$ |
45,069 |
|
||||
Reconciliation of Adjusted Net Income to Net Income: (3) | ||||||||||||||||
Net income |
$ |
11,250 |
|
$ |
11,597 |
|
$ |
19,720 |
|
$ |
20,491 |
|
||||
(Gain) Loss on sale of assets, net of tax |
|
(1 |
) |
|
12 |
|
|
(1 |
) |
|
12 |
|
||||
Impact of retroactive |
|
- |
|
|
(1,054 |
) |
|
- |
|
|
- |
|
||||
COVID-19 expense, net of tax |
|
- |
|
|
- |
|
|
- |
|
|
(479 |
) |
||||
Acquisition and de novo expenses, net of tax |
|
1,394 |
|
|
1,790 |
|
|
3,407 |
|
|
3,142 |
|
||||
Stock-based compensation expense, net of tax |
|
2,013 |
|
|
1,851 |
|
|
3,804 |
|
|
3,666 |
|
||||
Restructure and other non-recurring costs, net of tax |
|
66 |
|
|
258 |
|
|
137 |
|
|
584 |
|
||||
Adjusted Net Income |
$ |
14,722 |
|
$ |
14,454 |
|
$ |
27,067 |
|
$ |
27,416 |
|
||||
Reconciliation of Net Income per Diluted Share to Adjusted Net Income per Diluted Share: (4) | ||||||||||||||||
Net income per diluted share |
$ |
0.70 |
|
$ |
0.72 |
|
$ |
1.22 |
|
$ |
1.28 |
|
||||
Impact of retroactive |
|
- |
|
|
(0.07 |
) |
|
- |
|
|
- |
|
||||
COVID-19 expense, net per diluted share |
|
- |
|
|
- |
|
|
- |
|
|
(0.03 |
) |
||||
Acquisition and de novo expenses per diluted share |
|
0.08 |
|
|
0.11 |
|
|
0.21 |
|
|
0.20 |
|
||||
Restructure and other non-recurring costs per diluted share |
|
- |
|
|
0.02 |
|
|
0.01 |
|
|
0.04 |
|
||||
Stock-based compensation expense per diluted share |
|
0.13 |
|
|
0.12 |
|
|
0.24 |
|
|
0.22 |
|
||||
Adjusted net income per diluted share |
$ |
0.91 |
|
$ |
0.90 |
|
$ |
1.68 |
|
$ |
1.71 |
|
||||
Reconciliation of Net Service Revenues to Adjusted Net Service Revenues: (5) | ||||||||||||||||
Net service revenues |
$ |
236,940 |
|
$ |
217,893 |
|
$ |
463,574 |
|
$ |
423,195 |
|
||||
Revenues associated with the closure of certain sites |
|
- |
|
|
(619 |
) |
|
- |
|
|
(1,287 |
) |
||||
Adjusted net service revenues |
$ |
236,940 |
|
$ |
217,274 |
|
$ |
463,574 |
|
$ |
421,908 |
|
||||
Footnotes: |
(1) The Company defined adjusted net income, adjusted EBITDA, and adjusted diluted earnings per share to exclude net COVID expenses arising from the pandemic from the second quarter of 2020 to the first quarter of 2021. |
(2) We define Adjusted EBITDA as earnings before interest expense, other non-operating income, taxes, depreciation, amortization, acquisition and de novo expense, stock-based compensation expense, restructure and other non-recurring costs, gain or loss on the sale of assets and retroactive rate increases from |
(3) We define Adjusted Net Income as net income before acquisition and de novo expenses, stock-based compensation expenses, restructure and other non-recurring costs, gain or loss on the sale of assets and retroactive rate increases from |
(4) We define Adjusted diluted earnings per share as earnings per share, adjusted for acquisition and de novo expenses, stock-based compensation expense, restructure and other non-recurring costs, gain or loss on the sale of assets and retroactive rate increases from |
(5) We define Adjusted net service revenues as revenue adjusted for the closure of certain sites. Adjusted net service revenues is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in |
View source version on businesswire.com: https://www.businesswire.com/news/home/20220801005643/en/
Executive Vice President, Chief Financial Officer
investorrelations@addus.com
(615) 324-7346
dru.anderson@finnpartners.com
Source: